295 related articles for article (PubMed ID: 26264352)
21. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
Al-Qasem A; Al-Howail HA; Al-Swailem M; Al-Mazrou A; Al-Otaibi B; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A
Mol Carcinog; 2016 Mar; 55(3):233-44. PubMed ID: 25641341
[TBL] [Abstract][Full Text] [Related]
22. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
23. Human colorectal CD24+ cancer stem cells are susceptible to epithelial-mesenchymal transition.
Okano M; Konno M; Kano Y; Kim H; Kawamoto K; Ohkuma M; Haraguchi N; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M; Ishii H
Int J Oncol; 2014 Aug; 45(2):575-80. PubMed ID: 24858473
[TBL] [Abstract][Full Text] [Related]
24. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness.
Wang Z; Li Y; Kong D; Sarkar FH
Curr Drug Targets; 2010 Jun; 11(6):745-51. PubMed ID: 20041844
[TBL] [Abstract][Full Text] [Related]
25. Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.
Nagaraju GP; Long TE; Park W; Landry JC; Taliaferro-Smith L; Farris AB; Diaz R; El-Rayes BF
Mol Carcinog; 2015 Oct; 54(10):1147-58. PubMed ID: 24861206
[TBL] [Abstract][Full Text] [Related]
26. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
27. Exploitation of the Notch signaling pathway as a novel target for cancer therapy.
Wang Z; Li Y; Banerjee S; Sarkar FH
Anticancer Res; 2008; 28(6A):3621-30. PubMed ID: 19189643
[TBL] [Abstract][Full Text] [Related]
28. Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy.
Bhangu A; Wood G; Mirnezami A; Darzi A; Tekkis P; Goldin R
Surg Oncol; 2012 Dec; 21(4):316-23. PubMed ID: 22981546
[TBL] [Abstract][Full Text] [Related]
29. Novel drug discovery opportunities for colorectal cancer.
Curtin JC
Expert Opin Drug Discov; 2013 Sep; 8(9):1153-64. PubMed ID: 23768167
[TBL] [Abstract][Full Text] [Related]
30. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
[TBL] [Abstract][Full Text] [Related]
31. Notch signaling in cardiac valve development and disease.
MacGrogan D; Luna-Zurita L; de la Pompa JL
Birth Defects Res A Clin Mol Teratol; 2011 Jun; 91(6):449-59. PubMed ID: 21563298
[TBL] [Abstract][Full Text] [Related]
32. Notch signaling and intestinal cancer.
Guilmeau S
Adv Exp Med Biol; 2012; 727():272-88. PubMed ID: 22399355
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis in cancer - general pathways and their therapeutic implications.
Dimova I; Popivanov G; Djonov V
J BUON; 2014; 19(1):15-21. PubMed ID: 24659637
[TBL] [Abstract][Full Text] [Related]
34. Notch, apoptosis and cancer.
Dang TP
Adv Exp Med Biol; 2012; 727():199-209. PubMed ID: 22399349
[TBL] [Abstract][Full Text] [Related]
35. Stemness, Inflammation and Epithelial-Mesenchymal Transition in Colorectal Carcinoma: The Intricate Network.
Briede I; Balodis D; Gardovskis J; Strumfa I
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884696
[TBL] [Abstract][Full Text] [Related]
36. Role of glycosylation of Notch in development.
Takeuchi H; Haltiwanger RS
Semin Cell Dev Biol; 2010 Aug; 21(6):638-45. PubMed ID: 20226260
[TBL] [Abstract][Full Text] [Related]
37. Notch-3 affects chemoresistance in colorectal cancer via DNA base excision repair enzymes.
George DC; Bertrand FE; Sigounas G
Adv Biol Regul; 2024 Jan; 91():101013. PubMed ID: 38290285
[TBL] [Abstract][Full Text] [Related]
38. Hedgehog-GLI and Notch Pathways Sustain Chemoresistance and Invasiveness in Colorectal Cancer and Their Inhibition Restores Chemotherapy Efficacy.
Citarella A; Catanzaro G; Besharat ZM; Trocchianesi S; Barbagallo F; Gosti G; Leonetti M; Di Fiore A; Coppola L; Autilio TM; Spinello Z; Vacca A; De Smaele E; Venneri MA; Ferretti E; Masuelli L; Po A
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900263
[TBL] [Abstract][Full Text] [Related]
39. MOGS promotes stemness acquisition and invasion via enhancing NOTCH1-glycosylation dependent NOTCH pathway in colorectal cancer.
Zhou S; Huang H; Zheng Z; Zheng K; Xie L
Am J Cancer Res; 2023; 13(12):5996-6010. PubMed ID: 38187061
[TBL] [Abstract][Full Text] [Related]
40. Targeting the death receptor signaling pathway as a potential therapeutic target in the treatment of colorectal cancer.
Moradi Marjaneh R; Hassanian SM; Ghobadi N; Ferns GA; Karimi A; Jazayeri MH; Nasiri M; Avan A; Khazaei M
J Cell Physiol; 2018 Oct; 233(10):6538-6549. PubMed ID: 29741789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
